In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported-Reference-Cited by-同舟云学术

In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

Published:2021-12-03 Issue:23 Volume:5 Page:5057-5059
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Anekpuritanang Tauangtham¹²^ORCID,Klairmont Matthew M.³^ORCID,Gradowski Joel³,Hagiwara Kohei⁴,Bailey Nathanael G.⁵,Chandra Pranil⁶,Liu Yiwei⁷,Mulder Heather L.⁴,Easton John⁴^ORCID,Zhang Jinghui⁴,Martin Michael G.⁸,Owczarczyk Anna B.⁹,Dunlap Jennifer B.¹,Fan Guang¹,Press Richard D.¹¹⁰^ORCID,Raess Philipp W.¹^ORCID

Affiliation:

1. Department of Pathology, Oregon Health and Science University, Portland, OR;

2. Department of Pathology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand;

3. Department of Pathology, University of Tennessee Health Science Center, Memphis, TN;

4. Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN;

5. Department of Pathology, University of Pittsburgh School of Medicine and UPMC, Pittsburgh, PA;

6. Genomic and Clinical Pathology, PathGroup, Nashville, TN and

7. Department of Pharmaceutical Sciences and

8. Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN;

9. Department of Pathology, University of Michigan, Ann Arbor, MI; and

10. Knight Cancer Institute, Oregon Health and Science University, Portland, OR

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/5/23/5057/1848857/advancesadv2021004983.pdf

Reference7 articles.

1. Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow;Lazarevic;Blood.,2018

2. Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations;Jutzi;Blood.,2019

3. Molecular discordance between myeloid sarcomas and concurrent bone marrows occurs in actionable genes and is associated with worse overall survival;Werstein;J Mol Diagn.,2020

4. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology;Richards;Genet Med.,2015

5. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists;Li;J Mol Diagn.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of common genomic signatures of Systemic juvenile rheumatoid arthritis and Kawasaki disease;2024-05-06

2. An Enhancer LncRNA Regulates NFE2 Expression and Proliferation in Human Leukemic K562 Cells*;PROG BIOCHEM BIOPHYS;2024

3. Myeloid sarcoma: An overview;Seminars in Diagnostic Pathology;2023-05

4. Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group;Leukemia & Lymphoma;2023-03-24